Literature DB >> 26321440

Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database.

Donald S Likosky1, Amelia S Wallace2, Richard L Prager3, Jeffrey P Jacobs4, Min Zhang5, Steven D Harrington6, Paramita Saha-Chaudhuri7, Patricia F Theurer3, Astrid Fishstrom3, Rachel S Dokholyan2, David M Shahian8, J Scott Rankin9.   

Abstract

BACKGROUND: Patients undergoing coronary artery bypass grafting (CABG) are at risk for a variety of infections. Investigators have focused on predictors of these adverse sequelae, but less attention has been focused on characterizing hospital-level variability in these outcomes.
METHODS: Between July 2011 and December 2013, The Society of Thoracic Surgeons Adult Cardiac Surgery Database shows 365,686 patients underwent isolated CABG in 1,084 hospitals. Hospital-acquired infections (HAIs) were defined as pneumonia, sepsis/septicemia, deep sternal wound infection/mediastinitis, vein harvest/cannulation site infection, or thoracotomy infection. Hospitals were ranked by their HAI rate as low (≤ 10th percentile), medium (10th to 90th percentile), and high (>90th percentile). Differences in perioperative factors and composite morbidity and mortality end points across these groups were determined using the Wilcoxon rank sum and χ(2) tests.
RESULTS: HAIs occurred among 3.97% of patients overall, but rates varied across hospital groups (low: <0.84%, medium: 0.84% to 8.41%, high: >8.41%). Pneumonia (2.98%) was the most common HAI, followed by sepsis/septicemia (0.84%). Patients at high-rate hospitals more often smoked, had diabetes, chronic lung disease, New York Heart Association Functional Classification III to IV, and received blood products (p < 0.001); however, they less often were prescribed the appropriate antibiotics (p < 0.001). Major morbidity and mortality occurred among 12.3% of patients, although this varied by hospital group (low: 8.6%, medium: 12.3%, high: 17.9%; p < 0.001).
CONCLUSIONS: Substantial hospital-level variation exists in postoperative HAIs among patients undergoing CABG, driven predominantly by pneumonia. Given the relatively small absolute differences in comorbidities across hospital groups, our findings suggest factors other than case mix may explain the observed variation in HAI rates.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321440      PMCID: PMC4898754          DOI: 10.1016/j.athoracsur.2015.05.015

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

1.  A statewide quality collaborative for process improvement: internal mammary artery utilization.

Authors:  Scott H Johnson; Patricia F Theurer; Gail F Bell; Luigi Maresca; Thomas Leyden; Richard L Prager
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

2.  Regulatory and ethical considerations for linking clinical and administrative databases.

Authors:  Rachel S Dokholyan; Lawrence H Muhlbaier; John M Falletta; Jeffrey P Jacobs; David Shahian; Constance K Haan; Eric D Peterson
Journal:  Am Heart J       Date:  2009-06       Impact factor: 4.749

3.  Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia.

Authors:  Alan M Speir; Vigneshwar Kasirajan; Scott D Barnett; Edwin Fonner
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

Review 4.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

Authors:  Victor A Ferraris; Jeremiah R Brown; George J Despotis; John W Hammon; T Brett Reece; Sibu P Saha; Howard K Song; Ellen R Clough; Linda J Shore-Lesserson; Lawrence T Goodnough; C David Mazer; Aryeh Shander; Mark Stafford-Smith; Jonathan Waters; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; Donald S Likosky; Kenneth G Shann
Journal:  Ann Thorac Surg       Date:  2011-03       Impact factor: 4.330

5.  Center-level variation in infection rates after coronary artery bypass grafting.

Authors:  Terry Shih; Min Zhang; Mallika Kommareddi; Theodore J Boeve; Steven D Harrington; Robert J Holmes; Gary Roth; Patricia F Theurer; Richard L Prager; Donald S Likosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07-01

6.  Contribution of infection to increased mortality in women after cardiac surgery.

Authors:  Mary A M Rogers; Kenneth M Langa; Catherine Kim; Brahmajee K Nallamothu; Laurence F McMahon; Preeti N Malani; Brant E Fries; Samuel R Kaufman; Sanjay Saint
Journal:  Arch Intern Med       Date:  2006-02-27

Review 7.  Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival.

Authors:  C A Milano; K Kesler; N Archibald; D J Sexton; R H Jones
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

8.  A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group.

Authors:  G T O'Connor; S K Plume; E M Olmstead; J R Morton; C T Maloney; W C Nugent; F Hernandez; R Clough; B J Leavitt; L H Coffin; C A Marrin; D Wennberg; J D Birkmeyer; D C Charlesworth; D J Malenka; H B Quinton; J F Kasper
Journal:  JAMA       Date:  1996-03-20       Impact factor: 56.272

9.  A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care.

Authors:  Damien J LaPar; Ivan K Crosby; Jeffrey B Rich; Edwin Fonner; Irving L Kron; Gorav Ailawadi; Alan M Speir
Journal:  Ann Thorac Surg       Date:  2013-08-21       Impact factor: 4.330

10.  Hospital variation in transfusion and infection after cardiac surgery: a cohort study.

Authors:  Mary A M Rogers; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Brahmajee K Nallamothu
Journal:  BMC Med       Date:  2009-07-31       Impact factor: 8.775

View more
  15 in total

1.  Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery.

Authors:  Donald S Likosky; Steven D Harrington; Lourdes Cabrera; Alphonse DeLucia; Carol E Chenoweth; Sarah L Krein; Dylan Thibault; Min Zhang; Roland A Matsouaka; Raymond J Strobel; Richard L Prager
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-11

2.  Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting.

Authors:  Alexander A Brescia; J Scott Rankin; Derek D Cyr; Jeffrey P Jacobs; Richard L Prager; Min Zhang; Roland A Matsouaka; Steven D Harrington; Rachel S Dokholyan; Steven F Bolling; Astrid Fishstrom; Sara K Pasquali; David M Shahian; Donald S Likosky
Journal:  Ann Thorac Surg       Date:  2017-11-23       Impact factor: 4.330

3.  Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network.

Authors:  Gorav Ailawadi; Helena L Chang; Patrick T O'Gara; Karen O'Sullivan; Y Joseph Woo; Joseph J DeRose; Michael K Parides; Vinod H Thourani; Sophie Robichaud; A Marc Gillinov; Wendy C Taddei-Peters; Marissa A Miller; Louis P Perrault; Robert L Smith; Lyn Goldsmith; Keith A Horvath; Kristen Doud; Kim Baio; Annetine C Gelijns; Alan J Moskowitz; Emilia Bagiella; John H Alexander; Alexander Iribarne
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-09       Impact factor: 5.209

4.  Hospital Variability Drives Inconsistency in Antiplatelet Use After Coronary Bypass.

Authors:  Jared P Beller; William Z Chancellor; J Hunter Mehaffey; Robert B Hawkins; Matthew R Byler; Alan M Speir; Mohammed A Quader; Andy C Kiser; Leora T Yarboro; Gorav Ailawadi; Nicholas R Teman
Journal:  Ann Thorac Surg       Date:  2020-02-11       Impact factor: 4.330

5.  Variation between hospitals in outcomes following cardiac surgery in the UK.

Authors:  G Soppa; P Theodoropoulos; R Bilkhu; D A Harrison; R Alam; R Beattie; D Bleetman; A Hussain; S Jones; L Kenny; M Khorsandi; A Lea; Ka Mensah; T N Hici; A C Pinho-Gomes; L Rogers; A Sepehripour; S Singh; D Steele; H Weaver; A Klein; N Fletcher; M Jahangiri
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

6.  A Preoperative Risk Model for Postoperative Pneumonia After Coronary Artery Bypass Grafting.

Authors:  Raymond J Strobel; Qixing Liang; Min Zhang; Xiaoting Wu; Mary A M Rogers; Patricia F Theurer; Astrid B Fishstrom; Steven D Harrington; Alphonse DeLucia; Gaetano Paone; Himanshu J Patel; Richard L Prager; Donald S Likosky
Journal:  Ann Thorac Surg       Date:  2016-06-01       Impact factor: 4.330

7.  Evaluating the Impact of Pneumonia Prevention Recommendations After Cardiac Surgery.

Authors:  Raymond J Strobel; Steven D Harrington; Chris Hill; Michael P Thompson; Lourdes Cabrera; Patricia Theurer; Penny Wilton; Divyakant B Gandhi; Alphonse DeLucia; Gaetano Paone; Xiaoting Wu; Min Zhang; Sarah L Krein; Richard L Prager; Donald S Likosky
Journal:  Ann Thorac Surg       Date:  2020-02-06       Impact factor: 4.330

8.  Determinants of Value in Coronary Artery Bypass Grafting.

Authors:  Alexander A Brescia; Joceline V Vu; Chang He; Jun Li; Steven D Harrington; Michael P Thompson; Edward C Norton; Scott E Regenbogen; John D Syrjamaki; Richard L Prager; Donald S Likosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-12

9.  Stage 1 acute kidney injury is independently associated with infection following cardiac surgery.

Authors:  Benjamin R Griffin; J Pedro Teixeira; Sophia Ambruso; Michael Bronsert; Jay D Pal; Joseph C Cleveland; T Brett Reece; David A Fullerton; Sarah Faubel; Muhammad Aftab
Journal:  J Thorac Cardiovasc Surg       Date:  2019-11-25       Impact factor: 5.209

10.  Plasma and Lung Tissue Pharmacokinetics of Ceftaroline Fosamil in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: an In Vivo Microdialysis Study.

Authors:  M Edlinger-Stanger; V Al Jalali; M Andreas; W Jäger; M Böhmdorfer; M Zeitlinger; D Hutschala
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.